story of the week
Long-Term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy in Metastatic Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology